| 別品名 |
Bcl-X; bcl-xL; BCL-XL/S; bcl-xS; BCL2L; BCLX; BCLXL; BCLXS; PPP1R52
|
| 種由来 |
Human
|
| 由来詳細 |
Recombinant
|
| Accession No.(Gene/Protein) |
NM_138578, Q07817, Q07817-1, A0A0S2Z3C5
|
| Gene Symbol |
BCL2L1
|
| タグ（タンパク質） |
C-terminal MYC/DDK
|
| 発現系 |
ヒト細胞
|
| 純度 |
>80% as determined by SDS-PAGE and Coomassie blue staining
|
| 分子量 |
25.9 kDa
|
| 構成内容 |
TrueORF cDNAクローンを用いてHEK293T細胞で発現させた完全長ヒトタンパク質です。
|
| その他 |
[Buffer]25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol
|
|
※サムネイル画像をクリックすると拡大画像が表示されます。
PARK2 E3 ubiquitin ligase ubiquitinates BCL-XL in vitro. Recombinant proteins BCL-XL (OriGene TP301314) and PARK2 were incubated in HEPES buffer, pH 8.0 containing E1, E2, ubiquitin, and Mg2+-ATP. Reactions were cultured for 10 min at 30 C, then 30 - 60 min at 37 C, and reaction samples were subjected to Western blot analysis. Figure cited from Neoplasia, PMID: 28038320
|
|
|
|
PARK2 E3 ubiquitin ligase ubiquitinates BCL-XL in vitro. Recombinant proteins BCL-XL (OriGene TP301314) and PARK2 were incubated in HEPES buffer, pH 8.0 containing E1, E2, ubiquitin, and Mg2+-ATP. Reactions were cultured for 10 min at 30 C, then 30 - 60 min at 37 C, and reaction samples were subjected to Western blot analysis. Figure cited from Neoplasia, PMID: 28038320
|
|
|
| メーカー |
品番 |
包装 |
|
ORG
|
TP301314
|
20 UG
[>50 ug/mL]
|
※表示価格について
| 当社在庫 |
なし
|
| 納期目安 |
約10日
|
| 保存温度 |
-７０℃
|
|
